Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Putting the theory of personalised medicine into practice

Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Prof John Gribben - Bart’s and
Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma ( Dr Wyndham Wilson -  National Cancer Institute, Bethesda, MD, USA;  Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman -  Roswell Park Cancer Institute, Buffalo, NY, USA;  Prof John Gribben - Bart’s and )
26 Sep 2012

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012

The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )
19 Jul 2012

Australia Pancreatic Cancer Genome Initiative

Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia
Australia Pancreatic Cancer Genome Initiative ( Dr Marina Pajic – The Garvan Institute of Medical Research, Darlinghurst, Australia )
18 Jul 2012

Potential for micro-RNA based cancer treatments

Prof Carlo Croce – Ohio State University, Columbus, USA
Potential for micro-RNA based cancer treatments ( Prof Carlo Croce – Ohio State University, Columbus, USA )
18 Jul 2012

Bevacizumab benefits beyond progression in TML study subgroups

Dr Thierry André – Hôpital Saint Antoine, Paris, France
Bevacizumab benefits beyond progression in TML study subgroups ( Dr Thierry André – Hôpital Saint Antoine, Paris, France )
17 Jul 2012

Translational and tailored, but can we afford it?

Prof Gordon McVie - European Institute of Oncology and ecancer
Translational and tailored, but can we afford it? ( Prof Gordon McVie - European Institute of Oncology and ecancer )
17 Jul 2012

Translational and tailored, but can we afford it?

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012

Cost efficiency of targeted therapy

Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy
Cost efficiency of targeted therapy ( Dr Maria Grazia Daidone - Foundazione IRCCS Istituto Nazionale dei Tumori, Italy )
17 Jul 2012